Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Shenzhen Geno-Immune Medical Institute

4 clinical trials · 4 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Shenzhen Geno-Immune Medical Institute

RECRUITINGPhase 1 / Phase 2NCT03184753

Genetically Modified T Cells Against Ovarian Cancer

The primary objectives are to evaluate the safety and efficacy of infusion of autologous ovarian cancer immunogene-modified T cells (OC-IgT cells).

Sponsor: Shenzhen Geno-Immune Medical InstituteEnrolling: 1001 location
Ovarian Cancer
RECRUITINGPhase 1 / Phase 2NCT07193966

NG2 and DLL3 CAR-T Cells Targeting Melanoma

The purpose of this study is to assess the feasibility, safety and efficacy of multiple CAR-T cell therapy which targets NG2 and DLL3 surface antigens in patients with relapsed...

Sponsor: Shenzhen Geno-Immune Medical InstituteEnrolling: 1001 location
Melanoma
RECRUITINGPhase 1 / Phase 2NCT07501156

H3K27M-specific Immune Effector Cells Targeting DMG/DIPG

The purpose of this study is to assess the feasibility, safety and efficacy of H3K27M-specific engineered immune effector (EIE) therapy in patients with high-risk, H3K27M-positive...

Sponsor: Shenzhen Geno-Immune Medical InstituteEnrolling: 301 location
Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
RECRUITINGNCT03727555

IT and IV Lentiviral Gene Therapy for X-ALD

This is a Phase I/II clinical trial of gene therapy for treating X-linked adrenoleukodystrophy using a high-safety, high-efficiency, self-inactivating lentiviral vector (LV)...

Sponsor: Shenzhen Geno-Immune Medical InstituteEnrolling: 301 location
X-linked Adrenoleukodystrophy